Stay updated with breaking news from Riyaz Bashir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Thrombolex, Inc. announced the enrollment of the first patient in the RESCUE II study using the BASHIR™ Endovascular Catheter for the treatment of acute...
The Bashir endovascular catheter was designed to maximize thrombus reduction via a pharmacomechanical infusion.
By Raashid Andrabi SRINAGAR: America’s Food and Drug Administration (FDA) has finally approved the Kashmir cardiologist’s life-saving device that helps in managing pulmonary embolism.
/cloudfront-us-east-1.images.arcpublishing.com/pmn/J454PWDKGNCDFIS2CYEIUVAEOM.jpg)
The device to treat pulmonary embolism got approval from the Food and Drug Administration.
A device known as the BASHIR™ Endovascular Catheter (THROMBOLEX, Inc.) significantly reduces the size of blood clots lodged in the pulmonary arteries, leading to improvement in heart function in patients with pulmonary embolism, researchers from the Lewis Katz School of Medicine at Temple University announced in a Late-Breaking Innovation session at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) conference in Boston.